Skip to main content

Table 3 Most prevalent drug resistant mutations in Plasmodium falciparum reported during recent years across Cameroon

From: Review of malaria situation in Cameroon: technical viewpoint on challenges and prospects for disease elimination

Gene

Drugs affected by gene mutations

Mutations detected in Cameroon

Sites reporting drug resistance

References

pfcrt

CQ, AQ, LM

K76T, M74I, N75E, K76 T, Q271K, I356K

Mutengene, Ebolowa, Yaoundé, Bertoua, Douala, Kyé-Ossi, Ngaoundéré, Garoua

[7, 17, 20, 147,148,149]

pfdhfr

SP

N511, C59R, S108N

Yaoundé, Mont-Cameroon, Ngaoundéré, Garoua

[17, 20, 147,148,149]

pfdhps

SP

K142N, I431V, S436A, A581G, A613S, K540E, A437G

Yaoundé, Mont-Cameroon, Mutengene, Garoua

[17, 20, 147, 149]

pfmdr-1

AQ, CQ, LM, MQ

N86Y, Y184F, D1246Y

Mutengene, Yaoundé, Garoua

[17, 20, 149]

pfkelch13

Artemisinine

K189Ta

Mont-Cameroon

[17]

  1. aThis mutation does not confer resistance to artemisinine
  2. Abbreviations: pfdhfr, P. falciparum dihydrofolate reductase; pfdhps, P. falciparum dihydropteroate synthase; pfcrt, P. falciparum chloroquine resistance transporter; pfmdr-1, P. falciparum multidrug resistance transporter 1; CQ, chloroquine; AQ, amodiaquine; LM, lumefantrine; SP, sulfadoxine-pyrimethamine; MQ, mefloquine